Valuation Neuland Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:20:23 2026-08-07 EDT			5-day change	1st Jan Change
22,843.55 ^INR	+6.25%		+18.87%	+50.38%

08-05	Neuland Laboratories Limited, Q1 2027 Earnings Call, Aug 05, 2026
08-05	Neuland Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	13,171	23,087	80,588	154,946	154,121	293,080	-	-
Change	-	75.28%	249.07%	92.27%	-0.53%	90.16%	-	-
Enterprise Value (EV) ¹	13,171	23,087	80,374	153,929	153,584	295,641	294,060	290,784
Change	-	75.28%	248.14%	91.52%	-0.22%	92.49%	-0.54%	-1.11%
P/E	20.6x	14.1x	26.9x	-	42.3x	60.1x	48.6x	34.5x
PBR	1.58x	-	6.32x	10.2x	8.27x	12.7x	10.2x	8.12x
PEG	-	0x	0.3x	-	-	1.8x	2.1x	0.8x
Capitalization / Revenue	1.38x	1.94x	5.17x	10.5x	7.62x	12x	10x	8.46x
EV / Revenue	1.38x	1.94x	5.16x	10.4x	7.59x	12.1x	10x	8.39x
EV / EBITDA	9.24x	8.49x	17.4x	47.6x	26.7x	40.4x	31.1x	24.5x
EV / EBIT	14.1x	-	19.9x	59.7x	31.8x	46.1x	34.9x	27.5x
EV / FCF	-35.3x	13.5x	68.4x	139x	-304x	68.6x	72.7x	48.4x
FCF Yield	-2.83%	7.41%	1.46%	0.72%	-0.33%	1.46%	1.38%	2.07%
Dividend per Share ²	-	10	14	12	34	-	41.2	47.69
Rate of return	-	0.56%	0.22%	0.1%	0.28%	-	0.18%	0.21%
EPS ²	49.74	127.4	233.9	-	283.7	380	469.7	661.4
Distribution rate	-	7.85%	5.99%	-	12%	-	8.77%	7.21%
Net sales ¹	9,511	11,912	15,586	14,768	20,230	24,419	29,283	34,642
EBITDA ¹	1,426	2,718	4,626	3,233	5,745	7,321	9,460	11,884
EBIT ¹	935.8	-	4,029	2,577	4,828	6,409	8,437	10,566
Net income ¹	638.2	1,635	3,001	2,601	3,640	4,798	6,265	8,532
Net Debt ¹	-	-	-214.1	-1,017	-536.9	2,561	979.4	-2,296
Reference price ²	1,026.60	1,799.45	6,281.30	12,076.95	12,012.65	22,843.55	22,843.55	22,843.55
Nbr of stocks (in thousands)	12,830	12,830	12,830	12,830	12,830	12,830	-	-
Announcement Date	5/10/22	5/11/23	5/10/24	5/15/25	5/12/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NEULAND LABORATORIES LIMITED	56.59x	11.4x	38.03x	-.--%	2.9B
ELI LILLY AND COMPANY	33.78x	12.37x	24.91x	0.57%	1,062B
JOHNSON & JOHNSON	28.59x	-	-	2.09%	619B
ABBVIE INC.	32.06x	7.3x	15.18x	2.84%	431B
ROCHE HOLDING AG	20.32x	4.82x	11.94x	2.74%	358B
NOVARTIS AG	21.87x	5.66x	14.12x	2.84%	293B
ASTRAZENECA PLC	20.44x	4.22x	11.99x	2.09%	247B
AMGEN INC.	25.38x	6.71x	11.89x	2.49%	219B
NOVO NORDISK A/S	13.28x	4.8x	10.09x	3.83%	200B
GILEAD SCIENCES, INC.	-40.65x	5.84x	32.95x	2.52%	162B
Average	21.16x	7.01x	19.01x	2.2%	359.52B
Weighted average by Cap.	24.45x	8.11x	18.30x	1.99%